Home > Authorities > Periodicals > Advances in pharmacological and pharmaceutical sciences > print

001     488458
005     20250112193729.0
022 _ _ |a 2633-4682
022 _ _ |a 1687-6334
|l 1687-6334
022 _ _ |a 1687-6342
022 _ _ |a 2633-4682
|l 2633-4682
022 _ _ |a 2633-4690
|l 2633-4690
024 7 _ |2 ZDBID
|a PERI:(DE-600)3026687-7
024 7 _ |2 ZDBPPN
|a ZDPPN:1211961559
024 7 _ |2 EZBID
|a PERI:(DE-606)97403
024 7 _ |2 OCLC
|a OCLC:1368972090
024 7 _ |2 OCLC
|a OCLC:1366410809
024 7 _ |2 JCR
|a JCR:ADV PHARM PHARM SCI
024 7 _ |2 ISI
|a WOS:ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES
024 7 _ |2 SCOPUS
|a SCOPUS:21101028570
024 7 _ |2 Medline
|a medline:101762941
024 7 _ |2 SCOPUS
|a SCOPUS:17700156777
024 7 _ |2 Medline
|a medline:101537654
030 _ _ |2 DE-600
|a APPSG4
035 _ _ |a PERI:(DE-600)3026687-7
040 _ _ |a 0005
|b ger
|c DE-101
|d JOIN²
|e JOIN² journal identification
041 _ _ |a eng
044 _ _ |c XD-US
082 _ _ |2 23sdnb
|a 610
|q DE-600
082 7 4 |2 23sdnb
|a 610
|q DE-600
210 0 _ |2 iso
|a Adv Pharmacol Sci
210 0 _ |2 iso
|a Adv Pharmacol Pharm Sci
210 0 _ |2 dnlm
|a Adv Pharmacol Pharm Sci
210 0 _ |2 iso
|a Adv Pharmacol Pharm Sci
210 0 _ |2 dnlm
|a Adv Pharmacol Sci
210 0 _ |2 iso
|a Adv Pharmacol Sci
242 2 0 |2 DE-600
|a Advances in pharmacological and pharmaceutical sciences
|y en
242 2 0 |2 DE-600
|a Advances in pharmacological and pharmaceutical sciences
245 _ _ |2 DE-600
|a Advances in pharmacological and pharmaceutical sciences
|h online, print
246 3 _ |2 DE-600
|a Advances in pharmacological and pharmaceutical sciences
246 3 _ |a Advances in pharmacological and pharmaceutical sciences
246 3 _ |2 DE-600
|a Advances in pharmacological sciences
260 _ _ |a New York, NY
|b Hindawi
|c 2020-
260 _ 1 |0 Host:(DE-Juel1)3021
|2 DE-Juel1
|a Hindawi
260 7 _ |2 DOAJ
|a United Kingdom
|b Wiley
|d 2024-11-14T09:56:47Z
|f Advances in Pharmacological Sciences
260 7 _ |2 DOAJ
|a United Kingdom
|b Wiley
|d 2024-11-14T09:56:47Z
|f Advances in Pharmacological and Pharmaceutical Sciences
264 3 1 |a New York, NY
|b Hindawi
|c 2020-
362 0 _ |2 DE-600
|a Volume 2020-
363 0 1 |2 DE-600
|8 1.1\x
|i 2020
365 _ _ |2 DOAJ
|a APC
|b 950
|c USD
|d 2024-11-14T09:56:47Z
380 _ _ |2 marcgt
|a journal
500 _ _ |a Automatically generated record. (Updated: 2024-12-18)
650 _ 7 |0 ASJC:2736
|2 ASJC
|a Pharmacology (medical)
650 _ 7 |0 ASJC:3000
|2 ASJC
|a General Pharmacology, Toxicology and Pharmaceutics
650 _ 7 |0 ASJC:1313
|2 ASJC
|a Molecular Medicine
650 _ 7 |0 ASJC:1605
|2 ASJC
|a Organic Chemistry
650 _ 7 |0 ASJC:1303
|2 ASJC
|a Biochemistry
653 1 0 |2 DOAJ
|a pharmacology
|d 2024-11-14T09:56:47Z
653 1 0 |2 DOAJ
|a Medicine: Therapeutics. Pharmacology
|d 2024-11-14T09:56:47Z
653 1 0 |2 DOAJ
|a pharmaceutics
|d 2024-11-14T09:56:47Z
653 1 0 |2 DOAJ
|a pharmacy
|d 2024-11-14T09:56:47Z
653 1 0 |2 DOAJ
|a drug delivery
|d 2024-11-14T09:56:47Z
653 1 0 |2 DOAJ
|a medicinal chemistry
|d 2024-11-14T09:56:47Z
776 0 8 |2 DE-600
|i Erscheint auch als
|n Druck-Ausgabe
|t Advances in pharmacological and pharmaceutical sciences
|x 2633-4682
780 0 0 |2 DE-600
|d New York, NY : Hindawi, 2008-2019
|h Online-Ressource
|i Fortsetzung von
|t Advances in pharmacological sciences
|w (DE-600)2397786-3
|x 1687-6342
856 4 _ |d 0
|u https://ezb.ur.de/?3026687-7
|y EZB
856 4 _ |d 0
|u https://onlinelibrary.wiley.com/page/journal/3152/homepage/author-guidelines
|y Instructions for Authors
856 4 _ |d 0
|u https://onlinelibrary.wiley.com/page/journal/3152/homepage/editorial-board
|y Editorial board
856 4 _ |d 0
|u https://onlinelibrary.wiley.com/page/journal/3152/homepage/open-access
|y APC information
856 4 _ |d 0
|u https://onlinelibrary.wiley.com/page/journal/3152/productinformation
|y Scope
856 4 _ |d 0
|u https://www.hindawi.com/journals/aps
|y Verlag = kostenfrei
856 4 _ |d 0
|u https://www.ncbi.nlm.nih.gov/pmc/journals/1381
|y Verlag = kostenfrei
880 1 _ |2 DE-600
|a Advances in pharmacological and pharmaceutical sciences
909 C O |o oai:juser.fz-juelich.de:914212
|p authority:PERI
|p authority
909 C O |o oai:juser.fz-juelich.de:914212
915 _ _ |0 StatID:(DE-HGF)3001
|2 StatID
|a DEAL Wiley
|d 2024-12-18
|w ger
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b ADV PHARM PHARM SCI : 2022
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0112
|2 StatID
|a WoS
|b Emerging Sources Citation Index
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2024-11-14T09:56:47Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2024-11-14T09:56:47Z
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Anonymous peer review
|d 2024-11-14T09:56:47Z
915 _ _ |0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|a Creative Commons Attribution CC BY (No Version)
|b DOAJ
|d 2024-11-14T09:56:47Z
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2024-12-18
980 _ _ |a PERI
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21